Daytime urotherapy in nocturnal enuresis: a randomised, controlled trial.


Journal

Archives of disease in childhood
ISSN: 1468-2044
Titre abrégé: Arch Dis Child
Pays: England
ID NLM: 0372434

Informations de publication

Date de publication:
06 2022
Historique:
received: 03 11 2021
accepted: 03 01 2022
pubmed: 26 1 2022
medline: 24 5 2022
entrez: 25 1 2022
Statut: ppublish

Résumé

According to international guidelines, children with enuresis are recommended urotherapy, or basic bladder advice, before treatment with evidence-based alternatives such as the enuresis alarm is given. The efficacy of this strategy has, however, not been supported by controlled studies. We wanted to test if basic bladder advice is useful in enuresis. Randomised, controlled trial. Paediatric outpatient ward, regional hospital. Treatment-naïve enuretic children aged ≥6 years, with no daytime incontinence. Three groups, each during 8 weeks: (A) basic bladder advice-that is, voiding and drinking according to a strict schedule and instructions regarding toilet posture, (B) enuresis alarm therapy and (C) no treatment (control group). Reduction in enuresis frequency during week 7-8 compared with baseline. The median number of wet nights out of 14 before and at the end of treatment were in group A (n=20) 12.5 and 11.5 (p=0.44), in group B (n=22) 11.0 and 3.5 (p<0.001) and in group C (n=18) 12.5 and 12.0 (p=0.55). The difference in reduction of enuresis frequency between the groups was highly significant (p=0.002), but no difference was found between basic bladder advice and controls. Urotherapy, or basic bladder advice, is ineffective as a first-line treatment of nocturnal enuresis. Enuretic children who are old enough to be bothered by their condition should be offered treatment with the alarm or desmopressin. NCT03812094.

Identifiants

pubmed: 35074830
pii: archdischild-2021-323488
doi: 10.1136/archdischild-2021-323488
pmc: PMC9125372
doi:

Banques de données

ClinicalTrials.gov
['NCT03812094']

Types de publication

Journal Article Randomized Controlled Trial Research Support, Non-U.S. Gov't

Langues

eng

Sous-ensembles de citation

IM

Pagination

570-574

Informations de copyright

© Author(s) (or their employer(s)) 2022. Re-use permitted under CC BY-NC. No commercial re-use. See rights and permissions. Published by BMJ.

Déclaration de conflit d'intérêts

Competing interests: None declared.

Références

J Pediatr Urol. 2013 Apr;9(2):234-43
pubmed: 23260268
J Pediatr Urol. 2015 Jun;11(3):153.e1-5
pubmed: 25975733
J Pediatr Urol. 2009 Apr;5(2):105-9
pubmed: 18996052
Scand J Urol Nephrol Suppl. 1997;183:79-82
pubmed: 9165615
J Urol. 1999 Sep;162(3 Pt 2):1049-54; discussion 1054-5
pubmed: 10458430
J Urol. 2010 Feb;183(2):441-7
pubmed: 20006865
Gastroenterology. 2016 Feb 15;:
pubmed: 27144631
Scand J Urol Nephrol. 1999 Feb;33(1):49-52
pubmed: 10100364
Angle Orthod. 2020 Jan;90(1):31-38
pubmed: 31306076
Int J Urol. 2017 Mar;24(3):174-182
pubmed: 28208214
J Urol. 2009 Dec;182(6):2893-9
pubmed: 19846154
Scand J Urol Nephrol. 2002;36(5):354-62
pubmed: 12487740
J Urol. 2004 Jan;171(1):408-10
pubmed: 14665944
J Wound Ostomy Continence Nurs. 2004 Jul-Aug;31(4):223-34
pubmed: 15851867
J Urol. 2013 Jul;190(1):29-36
pubmed: 23313210
Neurourol Urodyn. 2017 Jan;36(1):43-50
pubmed: 26473630
J Pediatr Urol. 2020 Feb;16(1):10-19
pubmed: 32278657
J Pediatr Urol. 2021 Apr;17(2):172-181
pubmed: 33478902
Acta Paediatr. 2004 Mar;93(3):386-9
pubmed: 15124844
Scand J Urol Nephrol Suppl. 1976;(37):1-106
pubmed: 150023
Acta Paediatr. 2017 May;106(5):806-811
pubmed: 28199734
J Urol. 2008 May;179(5):1997-2002
pubmed: 18355856
J Urol. 2014 Jun;191(6):1863-1865.e13
pubmed: 24508614
J Natl Med Assoc. 2002 Jul;94(7):577-80
pubmed: 12126283
J Pediatr Urol. 2017 Dec;13(6):615.e1-615.e6
pubmed: 28634090
Cochrane Database Syst Rev. 2001;(1):CD002911
pubmed: 11279776
Pediatrics. 2008 Nov;122(5):1027-32
pubmed: 18977983

Auteurs

Malin Borgström (M)

Center for Clinical Research Dalarna, Falun, Sweden.
Department of Women's and Children's Health, Uppsala University, Uppsala, Sweden.

Amadeus Bergsten (A)

Department of Women's and Children's Health, Uppsala University, Uppsala, Sweden.

Maria Tunebjer (M)

Department of Women's and Children's Health, Uppsala University, Uppsala, Sweden.

Barbro Hedin Skogman (B)

Center for Clinical Research Dalarna, Uppsala University, Falun, Sweden.
Institution of Medical and Health Sciences, Örebro University, Örebro, Sweden.

Tryggve Nevéus (T)

Department of Women's and Children's Health, Uppsala University, Uppsala, Sweden Tryggve.Neveus@kbh.uu.se.

Articles similaires

[Redispensing of expensive oral anticancer medicines: a practical application].

Lisanne N van Merendonk, Kübra Akgöl, Bastiaan Nuijen
1.00
Humans Antineoplastic Agents Administration, Oral Drug Costs Counterfeit Drugs

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female
Humans United States Aged Cross-Sectional Studies Medicare Part C
1.00
Humans Yoga Low Back Pain Female Male

Classifications MeSH